TOKYO (Reuters) – The Group of Seven (G7) rich nations is set to agree on establishing a new program to distribute vaccines to developing countries at next week’s summit of leaders, Japan’s Yomiuri newspaper said on Saturday.
In addition to the G7, G20 nations such as India and international groups such as the World Health Organization (WHO) and the World Bank will participate, it added, citing Japanese government sources.
During the COVID-19 pandemic, the COVAX facility, backed by WHO and the Global Alliance for Vaccines and Immunization (GAVI), delivered nearly 2 billion doses of coronavirus vaccine to emerging countries.
However, COVAX faced setbacks in ensuring equitable access, as wealthy nations prioritised shots for their citizens while insufficient storage facilities in poorer nations caused supply delays and disposal of millions of close-to-expiry doses.
The new program aims to pool rainy-day funds for vaccine production and purchases, as well as investment in low-temperature storages and training of health workers to prepare for the next global pandemic, the paper said.
Japan, this year’s chair of the G7 meetings, looks to build support from emerging nations on wide-ranging issues such as supply chains, food security and climate change to counter the growing influence of China and Russia.
Saturday’s meeting of G7 finance ministers agreed to offer aid to low- and middle-income countries to help increase their role in supply chains for energy-related products.
The G7 grouping of Britain, Canada, the European Union, France, Germany, Italy, Japan and the United States, is considering whether to issue a statement on global pandemic response at the May 19-21 summit in Japan’s city of Hiroshima, the Yomiuri said.
Details of the new vaccine program are to be discussed at the G20 Summit in India in September, it added.
(Reporting by Kantaro Komiya; Editing by Clarence Fernandez)
